Association Between Factor VIII Inhibitor Level and Orthopedic Complications in Hemophilic Patients
Mirette Hazem Halim Hanna;
Abstract
A major complication in the treatment of HA is the development of antibodies that inactivate the procoagulant activity of FVIII, increasing the risk of bleeding, physical disability and mortality. Inhibitors occur mainly in children soon after onset of th
Other data
| Title | Association Between Factor VIII Inhibitor Level and Orthopedic Complications in Hemophilic Patients | Other Titles | العلاقة بين نسبة مثبط عامل التجلط رقم"8" لدى مرضى الهيموفيلية و مضاعفات العظام | Authors | Mirette Hazem Halim Hanna | Keywords | Association Between Factor VIII Inhibitor Level and Orthopedic Complications in Hemophilic Patients | Issue Date | 2009 | Description | A major complication in the treatment of HA is the development of antibodies that inactivate the procoagulant activity of FVIII, increasing the risk of bleeding, physical disability and mortality. Inhibitors occur mainly in children soon after onset of th |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.